Camden Partners closes VC fund to new investors

Baltimore investment firm Camden Partners Holdings, LLC announced Thursday that it has closed its venture capital fund, Camden Partners Nexus Fund, LP to new investors. The fund is the firm's first venture capital fund and focuses on early-stage biomedical technology companies, including drugs, devices, diagnostics and data analytics. It also focuses on investing in companies with intellectual ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.